General Information of the Disease (ID: M6ADIS0109)
Name
Liver disease
ICD
ICD-11: DB9Z
Full List of Target Gene(s) of This m6A-centered Disease Response
DNA damage-inducible transcript 3 protein (DDIT3/CHOP)
In total 1 item(s) under this target gene
Experiment 1 Reporting the m6A-centered Disease Response by This Target Gene [1]
Response Summary METTL14 promotes DNA damage-inducible transcript 3 protein (DDIT3/CHOP) mRNA decay through its 3' UTR N6-methyladenosine (m6A) to inhibit its downstream pro-apoptotic target gene expression, suppress ER proteotoxic liver disease. UPR induces METTL14 expression by competing against the HRD1-ER-associated degradation (ERAD) machinery to block METTL14 ubiquitination and degradation.
Responsed Disease Liver disease [ICD-11: DB9Z]
Target Regulator Methyltransferase-like 14 (METTL14) WRITER
Target Regulation Down regulation
Pathway Response Ubiquitin mediated proteolysis hsa04120
Cell Process Cell apoptosis
Ubiquitination degradation
In-vitro Model HEK293 Normal Homo sapiens CVCL_0045
Hep-G2 Hepatoblastoma Homo sapiens CVCL_0027
High mobility group protein B1 (HMGB1)
In total 1 item(s) under this target gene
Experiment 1 Reporting the m6A-centered Disease Response by This Target Gene [2]
Response Summary ALKBH5-dependent High mobility group protein B1 (HMGB1) expression mediates STING-interferon regulatory factor 3 innate immune response in radiation-induced liver diseases.
Responsed Disease Liver disease [ICD-11: DB9Z]
Target Regulator RNA demethylase ALKBH5 (ALKBH5) ERASER
Target Regulation Down regulation
Cell Process Immune Response
Cell apoptosis
Mammalian target of rapamycin complex 1 (mTORC1)
In total 1 item(s) under this target gene
Experiment 1 Reporting the m6A-centered Disease Response by This Target Gene [3]
Response Summary Mammalian target of rapamycin complex 1 (mTORC1) pathway is highly activated in rbm15-deficient hepatocytes. Rapamycin treatment partially restored normal hepatic gene expression as well as the nuclear location of the transcription factor Hnf4a. Taken together, these results reveal an unexpected role of Rbm15 in liver maturation.
Responsed Disease Liver disease [ICD-11: DB9Z]
Target Regulator RNA-binding motif protein 15 (RBM15) WRITER
Target Regulation Down regulation
Pathway Response mTOR signaling pathway hsa04150
Cell Process Cell proliferation and apoptosis
In-vivo Model Zebrafish (Danio rerio) AB strain-derived Tg(lfabp:Dendra2-NTR)cq1 was used as WT, and rbm15cq96 mutant was generated by ENU treatment.
Stimulator of interferon genes protein (STING1)
In total 1 item(s) under this target gene
Experiment 1 Reporting the m6A-centered Disease Response by This Target Gene [2]
Response Summary ALKBH5-dependent HMGB1 expression mediates Stimulator of interferon genes protein (STING1)-interferon regulatory factor 3 innate immune response in radiation-induced liver diseases.
Responsed Disease Liver disease [ICD-11: DB9Z]
Target Regulator RNA demethylase ALKBH5 (ALKBH5) ERASER
Target Regulation Down regulation
Cell Process Immune Response
Cell apoptosis
References
Ref 1 HRD1-mediated METTL14 degradation regulates m(6)A mRNA modification to suppress ER proteotoxic liver disease. Mol Cell. 2021 Dec 16;81(24):5052-5065.e6. doi: 10.1016/j.molcel.2021.10.028. Epub 2021 Nov 29.
Ref 2 ALKBH5-Modified HMGB1-STING Activation Contributes to Radiation Induced Liver Disease via Innate Immune Response. Int J Radiat Oncol Biol Phys. 2021 Oct 1;111(2):491-501. doi: 10.1016/j.ijrobp.2021.05.115. Epub 2021 May 24.
Ref 3 Loss of the RNA-binding protein Rbm15 disrupts liver maturation in zebrafish. J Biol Chem. 2020 Aug 14;295(33):11466-11472. doi: 10.1074/jbc.RA120.014080. Epub 2020 Jun 9.